Alphabet remains a compelling investment due to its dominant digital advertising position, limited China exposure, and strong ...

On-again, off-again policies from Washington, the onset of global tariff salvos, and flagging consumer and business ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

Many income investors use the FTSE 100 as their hunting ground for lucrative dividend stocks. However, there’s still plenty ...